[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000494:pharmacology*; D044482:Benzeneacetamides; D004594:Electrophysiology; D016700:Encainide; D005424:Flecainide; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology; D008801:Mexiletine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011405:Propafenone; D011427:Propiophenones / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology; D016677:Tocainide
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D007093:Imidazoles; D010880:Piperidines; D011427:Propiophenones; D008801:Mexiletine; D016677:Tocainide; D011405:Propafenone; D008012:Lidocaine; D013015:Sotalol; D005424:Flecainide; C015970:lorcainide; D016700:Encainide; C032151:cifenline
Antiarythmiques nouveaux: méxilétine, tocaïnide, lorcaïnide, encaïnide, flécaïnide, propafénone, cipralan, sotalol.